The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Cell & Gene
    • Bioprocessing
    • Drug Delivery
    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Regulation & Standards
    • Small Molecules
    • Supply Chain
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • eBooks
    • Content Hubs
Subscribe
Subscribe
The Medicine Maker / Issues / 2026 / June / How Zealand Pharma Is Scaling Quality Without Complexity
Bioprocessing Interviews Technology & Manufacturing Digital Technologies Quality & Compliance Regulation & Standards Standards & Regulation Sponsored

How Zealand Pharma Is Scaling Quality Without Complexity

How connected quality systems can help growing biotechs remain agile.

06/29/2026 0 min read Video

Share

As biotech companies grow, so does the complexity of their quality processes. How can teams expand without creating disconnected systems, duplicated work, and barriers for users?

Kamilla Vagtborg, Director and Head of Quality Systems at Zealand Pharma, explains how bringing documents, training, quality processes, and validation into one ecosystem can improve transparency and make information easier to navigate. She also discusses the value of investing in the right infrastructure early while keeping systems simple and adaptable as the organization evolves.

Watch the interview.

Newsletters

Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Recommended

Related Content

Musings from The Power List: Andres Sirulnik
Development & Clinical Biopharma Interviews
Musings from The Power List: Andres Sirulnik

October 5, 2026

4 min read

Regeneron's L. Andres Sirulnik explains why modernizing clinical trials is as important as developing new medicines

Musings from The Power List: Fabian Gerlinghaus
Development & Clinical Cell & Gene Interviews
Musings from The Power List: Fabian Gerlinghaus

October 1, 2026

3 min read

Cellares Co-Founder and CEO discusses why the future of cell therapy depends on rethinking how therapies are made

Musings from The Power List: Renee Aguiar-Lucander
Biopharma Development & Clinical Interviews
Musings from The Power List: Renee Aguiar-Lucander

September 28, 2026

2 min read

Renee Aguiar-Lucander argues that faster clinical trials and more pragmatic regulation are essential to bringing medicines to patients sooner

Musings from The Power List: Michael May
Cell & Gene Development & Clinical Interviews
Musings from The Power List: Michael May

September 22, 2026

5 min read

CCRM CEO Michael May on quantum computing, commercialization, and the next era of cell therapy

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions: